HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,689 | +41.2% | 690 | 0.0% | 0.00% | – |
| Q2 2023 | $8,280 | -24.7% | 690 | -18.3% | 0.00% | – |
| Q1 2023 | $11,002 | -70.3% | 845 | -66.3% | 0.00% | – |
| Q4 2022 | $37,024 | +68.3% | 2,505 | +0.4% | 0.00% | – |
| Q3 2022 | $22,000 | -51.1% | 2,495 | -30.4% | 0.00% | – |
| Q2 2022 | $45,000 | -35.7% | 3,587 | -2.7% | 0.00% | – |
| Q1 2022 | $70,000 | +100.0% | 3,687 | +270.9% | 0.00% | – |
| Q4 2021 | $35,000 | -12.5% | 994 | -8.6% | 0.00% | – |
| Q3 2021 | $40,000 | -25.9% | 1,088 | -20.4% | 0.00% | – |
| Q2 2021 | $54,000 | +42.1% | 1,366 | +1.9% | 0.00% | – |
| Q1 2021 | $38,000 | -9.5% | 1,341 | +2.8% | 0.00% | – |
| Q4 2020 | $42,000 | 0.0% | 1,305 | 0.0% | 0.00% | – |
| Q3 2020 | $42,000 | +740.0% | 1,305 | +650.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 174 | -21.3% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 221 | +30.8% | 0.00% | – |
| Q4 2019 | $4,000 | – | 169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Karst Peak Capital Ltd | 1,349,185 | $43,430,000 | 78.86% |
| AIA Investment Management Private Ltd | 354,035 | $11,396,000 | 2.43% |
| Bellevue Group AG | 400,029 | $12,877,000 | 0.82% |
| Prince Street Capital Management LLC | 81,400 | $2,620,000 | 0.55% |
| PRUDENTIAL PLC | 4,247,748 | $136,735,000 | 0.44% |
| OppenheimerFunds, Inc. | 2,936,797 | $94,536,000 | 0.11% |
| SECTORAL ASSET MANAGEMENT INC | 31,628 | $1,018,000 | 0.11% |
| Tibra Equities Europe Ltd | 27,900 | $898,000 | 0.11% |
| Jabre Capital Partners S.A. | 10,000 | $322,000 | 0.11% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1,803,955 | $58,069,000 | 0.10% |